 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.5.1.1.1
- Alanine racemase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-alanine = D-alanine
|
 |
 |
 |
 |
 |
L-alanine
|
=
|
D-alanine
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Pyridoxal 5'-phosphate
|
 |
 |
 |
 |
 |
Pyridoxal 5'-phosphate
Bound ligand (Het Group name =
EPC)
matches with 65.00% similarity
|
|
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
cell wall organization
|
4 terms
|
 |
|
Biochemical function
|
catalytic activity
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
33:5745-5758
(1994)
|
|
PubMed id:
|
|
|
|
|
| |
|
Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds.
|
|
K.A.Watson,
E.P.Mitchell,
L.N.Johnson,
J.C.Son,
C.J.Bichard,
M.G.Orchard,
G.W.Fleet,
N.G.Oikonomakos,
D.D.Leonidas,
M.Kontou.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
alpha-D-Glucose is a weak inhibitor of glycogen phosphorylase b (Ki = 1.7 mM)
and acts as a physiological regulator of hepatic glycogen metabolism. Glucose
binds to phosphorylase at the catalytic site and results in a conformational
change that stabilizes the inactive T state of the enzyme, promoting the action
of protein phosphatase 1 and stimulating glycogen synthase. It has been
suggested that, in the liver, glucose analogues with greater affinity for
glycogen phosphorylase may result in a more effective regulatory agent. Several
alpha- and beta-anhydroglucoheptonic acid derivatives and
1-deoxy-1-thio-beta-D-glucose analogues have been synthesized and tested in a
series of crystallographic and kinetic binding studies with glycogen
phosphorylase. The structural results of the bound enzyme-ligand complexes have
been analyzed, together with the resulting affinities, in an effort to
understand and exploit the molecular interactions that might give rise to a
better inhibitor. This work has shown the following: (i) Similar affinities may
be obtained through different sets of interactions. Specifically, in the case of
the alpha- and beta-glucose-C-amides, similar Ki's (0.37 and 0.44 mM,
respectively) are obtained with the alpha-anomer through interactions from the
ligand via water molecules to the protein and with the beta-anomer through
direct interaction from the ligand to the protein. Thus, hydrogen bonds through
water can contribute binding energy similar to that of hydrogen bonds directly
to the protein. (ii) Attempts to improve the inhibition by additional groups did
not always lead to the expected result. The addition of nonpolar groups to the
alpha-carboxamide resulted in a change in conformation of the pyranose ring from
a chair to a skew boat and the consequent loss of favorable hydrogen bonds and
increase in the Ki. (iii) The addition of polar groups to the alpha-carboxamide
led to compounds with the chair conformation, and in the examples studied, it
appears that hydration by a water molecule may provide sufficient stabilization
to retain the chair conformation. (iv) The best inhibitor was
N-methyl-beta-glucose-C-carboxamide (Ki = 0.16 mM), which showed a 46-fold
improvement in Ki from the parent beta-D-glucose. The decrease in Ki may be
accounted for by a single hydrogen bond from the amide nitrogen to a main-chain
carbonyl oxygen, an increase in entropy through displacement of a water
molecule, and favorable van der Waals contacts between the methyl substituent
and nonpolar protein residues.(ABSTRACT TRUNCATED AT 250 WORDS)
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.K.Malde,
and
A.E.Mark
(2011).
Challenges in the determination of the binding modes of non-standard ligands in X-ray crystal complexes.
|
| |
J Comput Aided Mol Des, 25,
1.
|
 |
|
|
|
|
 |
L.L.Lairson,
B.Henrissat,
G.J.Davies,
and
S.G.Withers
(2008).
Glycosyltransferases: structures, functions, and mechanisms.
|
| |
Annu Rev Biochem, 77,
521-555.
|
 |
|
|
|
|
 |
T.Hadjiloi,
C.Tiraidis,
E.D.Chrysina,
D.D.Leonidas,
N.G.Oikonomakos,
P.Tsipos,
and
T.Gimisis
(2006).
Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
|
| |
Bioorg Med Chem, 14,
3872-3882.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.D.Chrysina,
M.N.Kosmopoulou,
C.Tiraidis,
R.Kardakaris,
N.Bischler,
D.D.Leonidas,
Z.Hadady,
L.Somsak,
T.Docsa,
P.Gergely,
and
N.G.Oikonomakos
(2005).
Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1, 3, 4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site.
|
| |
Protein Sci, 14,
873-888.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.Archontis,
K.A.Watson,
Q.Xie,
G.Andreou,
E.D.Chrysina,
S.E.Zographos,
N.G.Oikonomakos,
and
M.Karplus
(2005).
Glycogen phosphorylase inhibitors: a free energy perturbation analysis of glucopyranose spirohydantoin analogues.
|
| |
Proteins, 61,
984-998.
|
 |
|
|
|
|
 |
K.A.Watson,
E.D.Chrysina,
K.E.Tsitsanou,
S.E.Zographos,
G.Archontis,
G.W.Fleet,
and
N.G.Oikonomakos
(2005).
Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase.
|
| |
Proteins, 61,
966-983.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Ambrosi,
N.R.Cameron,
and
B.G.Davis
(2005).
Lectins: tools for the molecular understanding of the glycocode.
|
| |
Org Biomol Chem, 3,
1593-1608.
|
 |
|
|
|
|
 |
N.G.Oikonomakos,
M.Kosmopoulou,
S.E.Zographos,
D.D.Leonidas,
E.D.Chrysina,
L.Somsák,
V.Nagy,
J.P.Praly,
T.Docsa,
B.Tóth,
and
P.Gergely
(2002).
Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies.
|
| |
Eur J Biochem, 269,
1684-1696.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Linden,
X.Li,
and
C.K.Lee
(2001).
Two ethyl 2-deoxy-alpha-D-hexo-3,7-pyranoso-3-octulosonate derivatives.
|
| |
Acta Crystallogr C, 57,
1418-1420.
|
 |
|
|
|
|
 |
J.L.Treadway,
P.Mendys,
and
D.J.Hoover
(2001).
Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.
|
| |
Expert Opin Investig Drugs, 10,
439-454.
|
 |
|
|
|
|
 |
N.G.Oikonomakos,
V.T.Skamnaki,
K.E.Tsitsanou,
N.G.Gavalas,
and
L.N.Johnson
(2000).
A new allosteric site in glycogen phosphorylase b as a target for drug interactions.
|
| |
Structure, 8,
575-584.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.E.Tsitsanou,
N.G.Oikonomakos,
S.E.Zographos,
V.T.Skamnaki,
M.Gregoriou,
K.A.Watson,
L.N.Johnson,
and
G.W.Fleet
(1999).
Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure.
|
| |
Protein Sci, 8,
741-749.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Chung,
D.Henriques,
D.Renzoni,
M.Zvelebil,
J.M.Bradshaw,
G.Waksman,
C.V.Robinson,
and
J.E.Ladbury
(1998).
Mass spectrometric and thermodynamic studies reveal the role of water molecules in complexes formed between SH2 domains and tyrosyl phosphopeptides.
|
| |
Structure, 6,
1141-1151.
|
 |
|
|
|
|
 |
M.Gregoriou,
M.E.Noble,
K.A.Watson,
E.F.Garman,
T.M.Krulle,
C.de la Fuente,
G.W.Fleet,
N.G.Oikonomakos,
and
L.N.Johnson
(1998).
The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding.
|
| |
Protein Sci, 7,
915-927.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.H.Martin,
D.J.Hoover,
S.J.Armento,
I.A.Stock,
R.K.McPherson,
D.E.Danley,
R.W.Stevenson,
E.J.Barrett,
and
J.L.Treadway
(1998).
Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.
|
| |
Proc Natl Acad Sci U S A, 95,
1776-1781.
|
 |
|
|
|
|
 |
E.P.Mitchell,
S.G.Withers,
P.Ermert,
A.T.Vasella,
E.F.Garman,
N.G.Oikonomakos,
and
L.N.Johnson
(1996).
Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states.
|
| |
Biochemistry, 35,
7341-7355.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.E.Ladbury
(1996).
Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design.
|
| |
Chem Biol, 3,
973-980.
|
 |
|
|
|
|
 |
D.Massillon,
M.Bollen,
H.De Wulf,
K.Overloop,
F.Vanstapel,
P.Van Hecke,
and
W.Stalmans
(1995).
Demonstration of a glycogen/glucose 1-phosphate cycle in hepatocytes from fasted rats. Selective inactivation of phosphorylase by 2-deoxy-2-fluoro-alpha-D-glucopyranosyl fluoride.
|
| |
J Biol Chem, 270,
19351-19356.
|
 |
|
|
|
|
 |
M.Board,
M.Hadwen,
and
L.N.Johnson
(1995).
Effects of novel analogues of D-glucose on glycogen phosphorylase activities in crude extracts of liver and skeletal muscle.
|
| |
Eur J Biochem, 228,
753-761.
|
 |
|
|
|
|
 |
N.G.Oikonomakos,
M.Kontou,
S.E.Zographos,
K.A.Watson,
L.N.Johnson,
C.J.Bichard,
G.W.Fleet,
and
K.R.Acharya
(1995).
N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.
|
| |
Protein Sci, 4,
2469-2477.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.G.Oikonomakos,
M.Kontou,
S.E.Zographos,
H.S.Tsitoura,
L.N.Johnson,
K.A.Watson,
E.P.Mitchell,
G.W.Fleet,
J.C.Son,
and
C.J.Bichard
(1994).
The design of potential antidiabetic drugs: experimental investigation of a number of beta-D-glucose analogue inhibitors of glycogen phosphorylase.
|
| |
Eur J Drug Metab Pharmacokinet, 19,
185-192.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|